Sanofi's riliprubart gets FDA orphan drug status for organ transplant rejection, unlocking key development perks.

Patients with occipital headache experienced relief with 60 days of peripheral nerve stimulation, according to data presented at the American Headache Society 67th Annual Scientific Meeting.“Whenever ...

Patients with migraine with aura show reduced migraine symptoms, less rescue medication use, and more sustained pain relief ...

The Global Neuropathic Pain Market is valued approximately at USD 8.14 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.73% over the forecast period 2024-2032.

Central nervous system; Peripheral nervous system; Systemic vasculitis; Connective tissue diseases; ... associated to infectious, malignant and connective tissue diseases (Chart 1). The latter cover a ...